Macquarie Group
AMRX icon

Macquarie Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Macquarie Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,684
Closed -$4.72K – 2475
2022
Q2 		$5K Hold
1,684
– – ﹤0.01% 2515
2022
Q1 		$7 Hold
1,684
– – ﹤0.01% 2546
2021
Q4 		$8K Hold
1,684
– – ﹤0.01% 2533
2021
Q3 		$9K Hold
1,684
– – ﹤0.01% 2546
2021
Q2 		$9K Hold
1,684
– – ﹤0.01% 2477
2021
Q1 		$11K Sell
1,684
-798
-32% -$4.42K ﹤0.01% 2374
2020
Q4 		$11K Hold
2,482
– – ﹤0.01% 2294
2020
Q3 		$10K Hold
2,482
– – ﹤0.01% 2279
2020
Q2 		$12K Buy
+2,482
New +$10.2K ﹤0.01% 2260
2018
Q3 		– Sell
-30,900
Closed -$507K – 2147
2018
Q2 		$507K Buy
+30,900
New +$542K ﹤0.01% 1363

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return